CEO Mark Capone describes Myriad’s innovative role in the development of molecular diagnostics. “We actually invented the research-based, education-centric business model for the diagnostic industry.”

Myriad Genetics at J.P. Morgan Healthcare Conference

Paul J. Diaz, president and chief executive officer, Bryan Riggsbee, chief financial officer, and Dale Muzzey, chief scientific officer, presented at the 41st annual J.P. Morgan (JPM) Healthcare Conference.